Bioequivalence of racemic drugs using non-steriospecific bio [Regulatives / Guidelines]

posted by scorp2011 – India, 2012-01-12 13:21  – Posting: # 7914
Views: 5,740

Dear ALL,
My question is related to the bioequivalence requirements of chiral drugs.
How to substantiate the use of achiral bio-analysis for racemic drugs with enantiomers having differing pharmacokinetics. Please also comments on the recommendations on the use of chiral/achiral methods as presented in the current Bioequivalence guideline (CPMP/QWP/EWP/1401/98 Rev.1).

Thanks in anticipation.

Regards
scorp

Complete thread:

Activity
 Admin contact
20,636 posts in 4,324 threads, 1,434 registered users;
online 15 (0 registered, 15 guests [including 10 identified bots]).
Forum time: 15:00 CEST (Europe/Vienna)

Facts do not cease to exist because they are ignored.    Aldous Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5